Biocept receives hong kong patent covering the enhanced detection of rare cells, including cancer cells

San diego, nov. 9, 2020 /prnewswire/ -- biocept, inc. (nasdaq: bioc), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes, announces that it has been awarded...
BIOC Ratings Summary
BIOC Quant Ranking